MedPath

Raphzep

Brand Name: Raphzep

Generic Name: Phenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol

Active
Registration Number

DRP-3400-01

Dosage Form

Syrup

Issuance Date

November 1, 2021

Expiry Date

November 22, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2.5mg/ 500mcg/ 125mg per 5mL
PackagingBoston Round, Glass Amber Bottle x 60mL

Classification

C
Classification
Over-The-Counter (OTC)
P
Pharmacologic
Decongestant/ Antihistamine/ Analgesic/ Antipyretic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Chlorpheniramine MaleateActive
Monograph: Chlorpheniramine
Phenylephrine HydrochlorideActive
Monograph: Phenylephrine
ParacetamolActive
Monograph: Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform